{"id":3844,"date":"2017-01-25T12:07:37","date_gmt":"2017-01-25T11:07:37","guid":{"rendered":"https:\/\/staging.blogs.yokogawa.de\/chemical-pharma\/unkategorisiert\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/"},"modified":"2022-07-04T06:53:48","modified_gmt":"2022-07-04T04:53:48","slug":"offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit","status":"publish","type":"post","link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/","title":{"rendered":"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit"},"content":{"rendered":"<blockquote><p><strong><em>Sich Neuen Technologien \u00f6ffnen, aber bei der Sicherheit keine Kompromisse machen.<\/em><\/strong><\/p><\/blockquote>\n<p><strong>Dr. Krauss, BASF<\/strong>, sagt noch viel mehr in seinem <a href=\"https:\/\/www.youtube.com\/watch?v=mgMVIPvEe3Q\">Interview<\/a> \u00fcber NAMUR Open Architecture auf der <a href=\"http:\/\/www.namur.net\/de\/publikationen\/news-archiv\/detail\/article\/namur-hauptsitzung-2016loesungen-zur-optimierung-in-der-globalen-prozessindustrie.html\">NAMUR-Hauptsitzung 2016<\/a>. Trotzdem bringt die Aussage es auf den Punkt. Mit der NAMUR Open Architecture (NOA) werden hier zurzeit neue Anforderungen \u00a0an die Architektur von Automatisierungssystemen diskutiert.<\/p>\n<h3>Ganzes Statement von Dr. Krauss ansehen!<\/h3>\n<h3>Yokogawas Version einer offenen Architektur<\/h3>\n<p>Dr. Helget, MD Deutschland, hat in der Keynote \u201eL\u00f6sungen zur Optimierung in der globalen Prozessindustrie\u201c Yokogawas Vision einer offenen Architektur bereits vorgestellt.<\/p>\n<p><span style=\"color: #ff0000\"><span style=\"color: #000000\">[ot-caption title=&#8221;Keynote-Slide: Offene Architektur \u2013 flexibel und zukunftssicher&#8221; url=&#8221;https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/app\/uploads\/2017\/01\/OpAr_Keynote_slide.png&#8221;]<\/span><br \/>\n<\/span><\/p>\n<h3>Keynote-Ausschnitt ansehen!<\/h3>\n<h3>Der Anfang ist gemacht<\/h3>\n<p>Den ersten Schritt hin zu einer offenen Architektur ist Yokogawa bereits gegangen. Mit der im September 2016 vorgestellten Version 2 der Unified Gateway Station (UGS2) kommt diese ohne die bisher ben\u00f6tigte systemeigene <a href=\"http:\/\/www.yokogawa.com\/de\/dcs\/offene_systemarchi\/de-vnet_ip.htm?nid=left\"> VNet\/IP Schnittstellenkarte<\/a> aus und nutzt stattdessen Standard Ethernet Technologien.<\/p>\n<p>[ot-caption title=&#8221;Unified Gateway Station 2: Fremdsysteme lassen sich \u00fcber eine Vielzahl von Schnittstellenprotokollen nahtlos in das Prozessleitsystem\u00a0 integrieren.&#8221; url=&#8221;https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/app\/uploads\/2017\/01\/openAr_UGS_DCS_Bild.png&#8221;]<\/p>\n<h3>Sicherheit geht vor<\/h3>\n<p>Bei der Sicherheit werden durch den Einsatz der\u00a0<a href=\"http:\/\/www.yokogawa.com\/de\/dcs\/offene_systemarchi\/de-vnet_ip.htm?nid=left\">VNet\/IP-Technologie<\/a> nach IEC 62405 keine Kompromisse gemacht. Neben der Vielzahl der unterst\u00fctzten Kommunikationsprotokolle (OPC, Modbus, Ethernet\/IP und andere) sind vor allem die Leistungsparameter beachtlich:<\/p>\n<ul>\n<li>Redundanz*<\/li>\n<li>Onlinef\u00e4higkeit<\/li>\n<li>nahtlosen Umschaltzeit von unter 1 Sekunde*<\/li>\n<li>256 Fremdsysteme\/UGS<\/li>\n<li>16 OPC-Server\/UGS<\/li>\n<li>600.000 Datenpunkte\/UGS<\/li>\n<li>450.000 Kommunikationsdatenpunkte\/UGS<\/li>\n<li>Durchsatzrate von 6.400 Daten\/sec.<\/li>\n<\/ul>\n<p style=\"padding-left: 30px\">*Einsatz von 2 <a href=\"https:\/\/web-material3.yokogawa.com\/GS33J20C20-01EN_001.pdf\">UGS<\/a><\/p>\n<p>Oder erfahren Sie mehr zu Yokogawas Systemstruktur <a href=\"http:\/\/www.yokogawa.com\/de\/dcs\/prozessleitsys\/de-systemstruktur.htm?nid=left\">hier<\/a>.<\/p>\n<p>Oder schreiben Sie Ihre Meinung zu dem Thema in die Kommentare. Ich freue mich \u00fcber den Austausch.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sich Neuen Technologien \u00f6ffnen, aber bei der Sicherheit keine Kompromisse machen. Dr. Krauss, BASF, sagt noch viel mehr in seinem Interview \u00fcber NAMUR Open Architecture auf der NAMUR-Hauptsitzung 2016. Trotzdem bringt die Aussage es auf den Punkt. Mit der NAMUR&hellip; <\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/\"> <span class=\"screen-reader-text\">Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit<\/span> Weiterlesen &raquo;<\/a><\/p>\n","protected":false},"author":105,"featured_media":956,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"","footnotes":""},"categories":[957,961],"tags":[],"coauthors":[1000],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.13 (Yoast SEO v20.13) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit - Chemical Pharma Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit\" \/>\n<meta property=\"og:description\" content=\"Sich Neuen Technologien \u00f6ffnen, aber bei der Sicherheit keine Kompromisse machen. Dr. Krauss, BASF, sagt noch viel mehr in seinem Interview \u00fcber NAMUR Open Architecture auf der NAMUR-Hauptsitzung 2016. Trotzdem bringt die Aussage es auf den Punkt. Mit der NAMUR&hellip;  Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit Weiterlesen &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemical Pharma Blog\" \/>\n<meta property=\"article:published_time\" content=\"2017-01-25T11:07:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-04T04:53:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"861\" \/>\n\t<meta property=\"og:image:height\" content=\"557\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Thomas Schindler\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/\"},\"author\":{\"name\":\"Thomas Schindler\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/adcd0fed5fe65f8f4d371d98235744b3\"},\"headline\":\"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit\",\"datePublished\":\"2017-01-25T11:07:37+00:00\",\"dateModified\":\"2022-07-04T04:53:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/\"},\"wordCount\":281,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization\"},\"articleSection\":[\"Automation\",\"Security\"],\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/\",\"name\":\"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit - Chemical Pharma Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website\"},\"datePublished\":\"2017-01-25T11:07:37+00:00\",\"dateModified\":\"2022-07-04T04:53:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/\",\"name\":\"Chemical Pharma Blog\",\"description\":\"Just another blogs.yokogawa.com Sites site\",\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization\",\"name\":\"Chemical Pharma Blog\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"contentUrl\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"width\":302,\"height\":89,\"caption\":\"Chemical Pharma Blog\"},\"image\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/adcd0fed5fe65f8f4d371d98235744b3\",\"name\":\"Thomas Schindler\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/image\/97a20917bd2189288e0eecb0d796610e\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/932374ee4344ac812a00cfd077571d4f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/932374ee4344ac812a00cfd077571d4f?s=96&d=mm&r=g\",\"caption\":\"Thomas Schindler\"},\"description\":\"responsible for Marketing Automation Solutions, expert for Distributed Control Systems, employed by Yokogawa since 1999\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/author\/thomas-schindler\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit - Chemical Pharma Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/","og_locale":"de_DE","og_type":"article","og_title":"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit","og_description":"Sich Neuen Technologien \u00f6ffnen, aber bei der Sicherheit keine Kompromisse machen. Dr. Krauss, BASF, sagt noch viel mehr in seinem Interview \u00fcber NAMUR Open Architecture auf der NAMUR-Hauptsitzung 2016. Trotzdem bringt die Aussage es auf den Punkt. Mit der NAMUR&hellip;  Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit Weiterlesen &raquo;","og_url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/","og_site_name":"Chemical Pharma Blog","article_published_time":"2017-01-25T11:07:37+00:00","article_modified_time":"2022-07-04T04:53:48+00:00","og_image":[{"width":861,"height":557,"url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg","type":"image\/jpeg"}],"author":"Thomas Schindler","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#article","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/"},"author":{"name":"Thomas Schindler","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/adcd0fed5fe65f8f4d371d98235744b3"},"headline":"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit","datePublished":"2017-01-25T11:07:37+00:00","dateModified":"2022-07-04T04:53:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/"},"wordCount":281,"commentCount":0,"publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization"},"articleSection":["Automation","Security"],"inLanguage":"de-DE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/","name":"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit - Chemical Pharma Blog","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website"},"datePublished":"2017-01-25T11:07:37+00:00","dateModified":"2022-07-04T04:53:48+00:00","breadcrumb":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/offene-systemarchitektur-ohne-kompromisse-in-der-sicherheit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/"},{"@type":"ListItem","position":2,"name":"Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit"}]},{"@type":"WebSite","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/","name":"Chemical Pharma Blog","description":"Just another blogs.yokogawa.com Sites site","publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization","name":"Chemical Pharma Blog","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","width":302,"height":89,"caption":"Chemical Pharma Blog"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/adcd0fed5fe65f8f4d371d98235744b3","name":"Thomas Schindler","image":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/image\/97a20917bd2189288e0eecb0d796610e","url":"https:\/\/secure.gravatar.com\/avatar\/932374ee4344ac812a00cfd077571d4f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/932374ee4344ac812a00cfd077571d4f?s=96&d=mm&r=g","caption":"Thomas Schindler"},"description":"responsible for Marketing Automation Solutions, expert for Distributed Control Systems, employed by Yokogawa since 1999","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/author\/thomas-schindler\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg",861,557,false],"thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S-150x150.jpg",150,150,true],"medium":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S-300x194.jpg",300,194,true],"medium_large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S-768x497.jpg",768,497,true],"large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg",861,557,false],"1536x1536":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg",861,557,false],"2048x2048":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S.jpg",861,557,false],"post-thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_100286097_S-356x200.jpg",356,200,true]},"uagb_author_info":{"display_name":"Thomas Schindler","author_link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/author\/thomas-schindler\/"},"uagb_comment_info":0,"uagb_excerpt":"Sich Neuen Technologien \u00f6ffnen, aber bei der Sicherheit keine Kompromisse machen. Dr. Krauss, BASF, sagt noch viel mehr in seinem Interview \u00fcber NAMUR Open Architecture auf der NAMUR-Hauptsitzung 2016. Trotzdem bringt die Aussage es auf den Punkt. Mit der NAMUR&hellip; Offene Systemarchitektur \u2013 ohne Kompromisse in der Sicherheit Weiterlesen &raquo;","_links":{"self":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/3844"}],"collection":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/users\/105"}],"replies":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/comments?post=3844"}],"version-history":[{"count":2,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/3844\/revisions"}],"predecessor-version":[{"id":11336,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/3844\/revisions\/11336"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/media\/956"}],"wp:attachment":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/media?parent=3844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/categories?post=3844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/tags?post=3844"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/coauthors?post=3844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}